Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
74 pending office actions • 48 clients • 72 examiners • 50 art units • 0 of 74 (0%) have an AI response strategy ready • 83 patents granted in the last 365 days
JMB Davis Ben-David focuses on Biotechnology & Pharmaceuticals and reports 1496 career applications. Its resolved allowance rate is 77.01%, with 72 pending office actions. The application total indicates a developed prosecution record, while the allowance rate describes results among resolved matters.
The firm averages 3.04 office actions per allowance, indicating that allowed cases have commonly required multiple examination exchanges. The 72 pending office actions identify an active current docket that requires ongoing deadline and response management. For a prospective client, the combination of a 77.01% resolved allowance rate and 3.04 average actions helps distinguish the likelihood of allowance from the prosecution activity typically needed to reach it.
Based on the USPTO statutory response window for each pending office action. 20 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 20 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 8 (11%) |
| §103 only | 17 (23%) |
| §102 only | 3 (4%) |
| §112 only | 8 (11%) |
| Double-patenting + other | 2 (3%) |
| Multi-statute (no §101) | 36 (49%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KIM, DANIELLE A | 2 | 36.6% | +51.9% |
| LANDSMAN, ROBERT S | 2 | 81.4% | +13.0% |
| PIERORAZIO, JILLIAN KUTCH | 1 | 59.3% | +32.1% |
| TANG, BRYANT | 1 | 86.1% | +0.2% |
| DEUTSCH, TAYLOR M | 1 | 53.3% | +36.3% |
| BROWN, SETH RICHARD | 1 | 48.9% | +44.3% |
| PEREZ-GUZMAN, CARLOS GABRIEL | 1 | 82.2% | +24.1% |
| LANE, DANIEL E | 1 | 3.8% | +8.3% |
| KIM, EUN HWA | 1 | 72.3% | +38.4% |
| CHONG, YONG SOO | 1 | 43.8% | +41.8% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19245335 | ROBOTIC DEVICE FOR DISTRIBUTING DESIGNATED ITEMS | TANG, BRYANT | — |
| 18681073 | PHARMACEUTICAL COMPOSITIONS COMPRISING HLA FUSION PROTEINS | LANDSMAN, ROBERT S | — |
| 18579526 | IDENTIFICATION OF COMMON TUMOR-SPECIFIC T CELL RECEPTORS AND ANTIGENS | LANDSMAN, ROBERT S | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18864564 | PHOTOVOLTAIC MODULE WITH SHADE-TOLERANT CELL-STRING LAYOUT | GONZALEZ RAMOS, MAYLA | 146d overdue |
| 18052223 | COMPOSITIONS, KITS AND METHODS FOR STYLING HAIR FIBERS | BABSON, NICOLE PLOURDE | 46d overdue |
| 18566650 | DEVICE FOR MIXING A BEVERAGE WITH A GAS | DIETERLE, JENNIFER M | 10d overdue |
| 18252194 | EXPRESSION SYSTEM AND METHOD FOR CONTROLLING A NETWORK IN A CELL AND CELL COMPRISING THE EXPRESSION SYSTEM | NICOL, ALEXANDER W | 5d overdue |
| 17920042 | RESUSCITATION DEVICE | SUL, DOUGLAS YOUNG | 7d |
| 18716940 | ELECTRODE CONFIGURATION AND METHOD FOR AURICULAR VAGAL NERVE STIMULATION | JIAN, SHIRLEY XUEYING | 9d |
| 18579512 | COMPUTER PROGRAM, METHOD, AND APPARATUS FOR DETERMINING A PLURALITY OF FUNCTIONAL OCULAR PARAMETERS | PYLE, SIENNA CHRISTINE | 16d |
| 18001074 | SMALL-MOLECULE INHIBITORS OF THE FRS2-FGFR INTERACTION AND THEIR USE IN MEDICINE, IN THE PREVENTION AND TREATMENT OF CANCER | HERNANDEZ, JACKSON J | 29d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19377096 | IMPACT MITIGATING STRUCTURE | PIERORAZIO, JILLIAN KUTCH | — |
| 19138132 | SCAR LIGHT MANIPULATOR | DEUTSCH, TAYLOR M | — |
| 19094914 | ADAPTATION SYSTEM FOR ORAL APPLIANCE | BROWN, SETH RICHARD | — |
| 19105880 | TURBIDITY SENSOR FOR MEASURING TURBIDITY OF A FLUID | PEREZ-GUZMAN, CARLOS GABRIEL | — |
| 18881287 | MULTI-ELECTRODE ARRAY DEVICE | KIM, EUN HWA | — |
| 18873352 | IONOPHORIC COPPER-CHELATORS IN COMBINATION WITH MAPK INHIBITORS FOR USE IN TREATMENT OF CANCER | CHONG, YONG SOO | — |
| 18702343 | COSMETIC COMPOSITIONS FOR USE IN SKIN CARE | KIM, DANIELLE A | — |
| 18444693 | COMPOSITIONS AND METHODS FOR STYLING HAIR FIBERS | KIM, DANIELLE A | — |
| Art Unit | Apps |
|---|---|
| 3732 | 3 |
| 2872 | 3 |
| 1791 | 3 |
| 1619 | 3 |
| 1618 | 3 |
| 1644 | 3 |
| 1793 | 3 |
| 3794 | 2 |
| 1613 | 2 |
| 1637 | 2 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19377096 | IMPACT MITIGATING STRUCTURE | Hexr Ltd. | PIERORAZIO, JILLIAN KUTCH | 3732 | §112 | Non-Final OA | — | Pending | Nov 03, 2025 |
| 19245335 | ROBOTIC DEVICE FOR DISTRIBUTING DESIGNATED ITEMS | Xtend AI Inc. | TANG, BRYANT | 3656 | §112 | Non-Final OA | — | Pending | Jun 22, 2025 |
| 19138132 | SCAR LIGHT MANIPULATOR | UNIVERSITAET ZUERICH | DEUTSCH, TAYLOR M | 3798 | §103 | Non-Final OA | — | Pending | Jun 12, 2025 |
| 19094914 | ADAPTATION SYSTEM FOR ORAL APPLIANCE | Pro3Dure Medical GmbH | BROWN, SETH RICHARD | 3772 | §102§112DP | Non-Final OA | — | Pending | Mar 30, 2025 |
| 19105880 | TURBIDITY SENSOR FOR MEASURING TURBIDITY OF A FLUID | Sensirion AG | PEREZ-GUZMAN, CARLOS GABRIEL | 2877 | §102§103§112 | Non-Final OA | — | Pending | Feb 24, 2025 |
| 19103245 | METHOD FOR DETERMINING A FATIGUE VALUE OF A PERSON | ETH ZÜRICH | LANE, DANIEL E | 3715 | §101§102§112 | Non-Final OA | 42d | Pending | Feb 12, 2025 |
| 18881287 | MULTI-ELECTRODE ARRAY DEVICE | Dyconex AG | KIM, EUN HWA | 3794 | §102§103 | Non-Final OA | — | Pending | Jan 05, 2025 |
| 18873352 | IONOPHORIC COPPER-CHELATORS IN COMBINATION WITH MAPK INHIBITORS FOR USE IN TREATMENT OF CANCER | UNIVERSITAET ZUERICH | CHONG, YONG SOO | 1623 | §103§112 | Non-Final OA | — | Pending | Dec 10, 2024 |
| 18864564 | PHOTOVOLTAIC MODULE WITH SHADE-TOLERANT CELL-STRING LAYOUT | Solarnative GmbH | GONZALEZ RAMOS, MAYLA | 1721 | §102§103§112 | Non-Final OA | 146d overdue | Pending | Nov 11, 2024 |
| 18862535 | MESH-GATEWAY NETWORK AND METHOD | Dryad Networks GmbH | HO, CHUONG T | 2469 | §103 | Non-Final OA | — | Pending | Nov 03, 2024 |
| 18854986 | 3T TANDEM SOLAR CELL, TANDEM SOLAR CELL MODULE, AND METHOD FOR PRODUCING SAME | Helmholtz-Zentrum Berlin Für Materialien Und Energie Gesellschaft Mit Beschränkter Haftung | AYAD, TAMIR | 1726 | §103§112 | Final Rejection | — | Pending | Oct 08, 2024 |
| 18904107 | METHOD AND SYSTEM FOR REDUCING ACTUATION FORCES FOR AN ADJUSTABLE OPTICAL ELEMENT | Optotune Switzerland AG | RICKEL, ALEX PARK | 2872 | §103§112 | Non-Final OA | — | Pending | Oct 02, 2024 |
| 18849509 | APPARATUS AND METHOD FOR DETECTING A FOREST FIRE | Dryad Networks GmbH | ONDREJCAK, ANDREW DOMENIC | 3752 | §102§103§112 | Non-Final OA | — | Pending | Sep 22, 2024 |
| 18751259 | LIQUID CONCENTRATE FOR SEASONING, WOOD PIECE USABLE AS FERMENTATION INDEX FOR SEASONING, KIT FOR MANUFACTURING SEASONING, METHOD FOR MANUFACTURING SEASONING, SEASONING, AND THICKENED SEASONING | Kikkoman Corporation | SMITH, CHAIM A | 1791 | §103§112 | Non-Final OA | — | Pending | Jun 23, 2024 |
| 18744642 | CALCIUM OXALATE CRYSTALLIZATION INHIBITORS FOR RENAL DISORDERS | VIFOR (INTERNATIONAL) AG | O DELL, DAVID K | 1621 | §103§112 | Non-Final OA | — | Pending | Jun 16, 2024 |
| 18719859 | METHOD FOR INSTALLING A TERMINAL OF A WILDFIRE EARLY DETECTION SYSTEM | Dryad Networks GmbH | ZEENDER, FLORIAN M | 3627 | §102§103 | Non-Final OA | — | Pending | Jun 14, 2024 |
| 18716940 | ELECTRODE CONFIGURATION AND METHOD FOR AURICULAR VAGAL NERVE STIMULATION | Cogniguard Medical Holdings Limited | JIAN, SHIRLEY XUEYING | 3792 | §103§112 | Final Rejection | 9d | Pending | Jun 06, 2024 |
| 18674990 | METHODS AND COMPOSITIONS FOR TREATING SPINAL CORD INJURY | Ramot AT Tel-Aviv University Ltd. | COUGHLIN, DANIEL F | 1619 | §102Other | Non-Final OA | — | Pending | May 27, 2024 |
| 18554806 | DISINFECTION DEVICE AND METHOD FOR THE DISINFECTION OF LIQUIDS AND GASES | Compact Laser Solutions GmbH | JOYNER, KEVIN | §102§112 | Non-Final OA | — | Pending | May 13, 2024 | |
| 18704515 | ANTIBODIES TARGETING PHOSPHORYLATED SEVEN-TRANSMEMBRANE RECEPTORS | 7Tm Antibodies GmbH | HOFFMAN, ALEXANDER JOSEPH | 1677 | §103§112 | Non-Final OA | — | Pending | Apr 25, 2024 |
| 18703344 | COMPOSITION FOR SINTERING COMPRISING AN ORGANIC SILVER PRECURSOR AND PARTICLES OF AGGLOMERATED SILVER NANOPARTICLES | Nano-Join GmbH | SMOOT, MORIAH SIMONE MCMIL | 1733 | §103§112 | Non-Final OA | — | Pending | Apr 21, 2024 |
| 18702343 | COSMETIC COMPOSITIONS FOR USE IN SKIN CARE | Gigi Cosmetic Laboratories Ltd. | KIM, DANIELLE A | 1613 | §102§103§112 | Non-Final OA | — | Pending | Apr 18, 2024 |
| 18701230 | NUCLEIC ACID AGENTS FOR TREATMENT OF NON-SMALL-CELL LUNG CANCER | UNIVERSITY COLLEGE DUBLIN | TRAN, CHRISTINA L | 1637 | §112 | Non-Final OA | — | Pending | Apr 14, 2024 |
| 18691491 | MINOR SPLICEOSOME TARGETING COMPOSITIONS AND THEIR USE IN CANCER TREATMENT | UNIVERSITÄT BERN | WARD, AARON DUREL | 1636 | §101§102§103§112 | Non-Final OA | — | Pending | Mar 13, 2024 |
| 18686456 | PURIFIED SIGNAL-ENHANCED CONTRAST AGENTS FOR MAGNETIC RESONANCE IMAGING | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | SAMALA, JAGADISHWAR RAO | 1618 | §102§103§112 | Non-Final OA | — | Pending | Feb 26, 2024 |
| 18444693 | COMPOSITIONS AND METHODS FOR STYLING HAIR FIBERS | Landa Labs (2012) Ltd. | KIM, DANIELLE A | 1613 | §103§112Other | Non-Final OA | — | Pending | Feb 18, 2024 |
| 18681073 | PHARMACEUTICAL COMPOSITIONS COMPRISING HLA FUSION PROTEINS | Immunos Therapeutics AG | LANDSMAN, ROBERT S | 1647 | §112Other | Non-Final OA | — | Pending | Feb 05, 2024 |
| 18579526 | IDENTIFICATION OF COMMON TUMOR-SPECIFIC T CELL RECEPTORS AND ANTIGENS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH | LANDSMAN, ROBERT S | 1647 | §103§112DP | Non-Final OA | — | Pending | Jan 16, 2024 |
| 18579512 | COMPUTER PROGRAM, METHOD, AND APPARATUS FOR DETERMINING A PLURALITY OF FUNCTIONAL OCULAR PARAMETERS | Machinemd AG | PYLE, SIENNA CHRISTINE | 3791 | §101§102§103§112 | Final Rejection | 16d | Pending | Jan 16, 2024 |
| 18579352 | HELMET WITH PROTECTIVE FEATURES | Hexr Ltd. | NGUYEN, UYEN T | 3732 | §103 | Final Rejection | 23d overdue | Pending | Jan 14, 2024 |
| 18575861 | METHODS FOR PRESERVING PLANT MATTER | Novagreen Technologies Ltd. | PILSBURY, BRADY CHARLES | 1799 | §102§103 | Non-Final OA | — | Pending | Jan 01, 2024 |
| 18398371 | HIGH-INTEGRITY R-WAVE TRIGGERED TUMOR THERAPY APPARATUS | Nanjing Zengcheng Biomedical Technology Co., Ltd. | GOOD, SAMANTHA M | 3794 | §103§112 | Non-Final OA | — | Pending | Dec 28, 2023 |
| 18571271 | VINYLATED KETO ESTERS WITH APPLICABILITY IN SIGNAL ENHANCED MAGNETIC RESONANCE IMAGING AND SYNTHESIS THEREOF | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | BAEK, JONGHWAN NMN | 1618 | §103§112 | Non-Final OA | — | Pending | Dec 18, 2023 |
| 18571232 | SEQUENTIAL INNATE AND ADAPTIVE IMMUNE MODULATION FOR CANCER TREATMENT | Gentechnologiestiftung- Dr. Georg Und Ingeburg Scheel Stiftung | WHITEMAN, BRIAN A | 1625 | §112 | Non-Final OA | — | Pending | Dec 17, 2023 |
| 18566650 | DEVICE FOR MIXING A BEVERAGE WITH A GAS | Mittemitte GmbH | DIETERLE, JENNIFER M | 1776 | §103§112 | Final Rejection | 10d overdue | Pending | Dec 03, 2023 |
| 18565545 | 3D PRINTING OF SOLID-STATE PHANTOMS | UNIVERSITÄT BERN | ILLING, CAITLIN NORINE | 1767 | §103§112 | Non-Final OA | — | Pending | Nov 30, 2023 |
| 18564090 | METHODS FOR IDENTIFYING CRITICALLY SHORT TELOMERES | Centarix Biotech Ltd. | HANEY, AMANDA MARIE | 1682 | §103 | Non-Final OA | — | Pending | Nov 26, 2023 |
| 18562853 | MEDICAL DEVICE COMPRISING A WEARABLE TEXTILE SENSOR TO PROTECT AGAINST PRESSURE INJURIES | Empa | DOUGHERTY, SEAN PATRICK | 3791 | §112 | Non-Final OA | — | Pending | Nov 21, 2023 |
| 18507202 | METHOD OF PRODUCING SPONGE CAKE | Shin-Etsu Chemical Co., Ltd. | CHAWLA, JYOTI | 1791 | §103 | Final Rejection | 30d overdue | Pending | Nov 13, 2023 |
| 18504227 | INTELLIGENT, MULTI-FUNCTION ROBOT | Xtend AI Inc. | NGUYEN, CUONG H | 3664 | §103 | Final Rejection | 27d | Pending | Nov 08, 2023 |
| 18558885 | ARENAVIRUSES AS VECTORS | Universtät Basel | CHEN, STACY BROWN | 1672 | §101§112 | Non-Final OA | — | Pending | Nov 03, 2023 |
| 18554819 | NON-COVALENT HALOTAG LIGANDS | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | CHAO, ALLEN | 1622 | §103 | Final Rejection | — | Pending | Oct 11, 2023 |
| 18548910 | STORAGE SYSTEM FOR CRYO-EM/ ET SAMPLES | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | MOORE, DEVON TYLEN | 3763 | §102§103 | Final Rejection | — | Pending | Sep 04, 2023 |
| 18460552 | IMAGING OPTICAL SYSTEM | Nextlens Switzerland AG | JONES, JENNIFER ANN | 2872 | §103 | Non-Final OA | 146d overdue | Pending | Sep 03, 2023 |
| 18548898 | CONFORMATIONAL CONSTRAINED SOMATOSTATIN RECEPTOR 3 PEPTIDE LIGANDS AND THEIR CONJUGATES AND USES THEREOF | Starget Pharma Ltd. | ROGERS, JAMES WILLIAM | 1618 | §102§103 | Final Rejection | 33d | Pending | Sep 03, 2023 |
| 18460549 | METHODS OF ANALYSIS OF ALLELIC EXPRESSION OF PIK3CA IN CANCER AND USES THEREOF | UNIVERSIDADE DO ALGARVE | SALMON, KATHERINE D | 1682 | §101§103§112 | Non-Final OA | — | Pending | Sep 03, 2023 |
| 18546795 | VIRAL DELIVERY OF A SIALIDASE TO TREAT CANCER | UNIVERSITÄT BASEL | ZARA, JANE J | 1637 | §103§112 | Non-Final OA | — | Pending | Aug 17, 2023 |
| 18264953 | USE OF MARKERS FOUND ON LYMPH NODE METASTATIC SAMPLES FOR THE PROGNOSIS OF BREAST CANCER | UNIVERSITAET ZUERICH | OUSPENSKI, ILIA I | 1644 | §103§112 | Non-Final OA | — | Pending | Aug 10, 2023 |
| 18263894 | MICROBIAL PRODUCTION OF TYROSOL AND SALIDROSIDE | Silicolife Lda. | EIX, EMILY FAY | 1653 | §103 | Final Rejection | 23d overdue | Pending | Aug 02, 2023 |
| 18353119 | MR1 RESTRICTED T CELL RECEPTORS FOR CANCER IMMUNOTHERAPY | UNIVERSITÄT BASEL | SKELDING, ZACHARY S | 1644 | §112 | Non-Final OA | — | Pending | Jul 17, 2023 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial77.0% of resolved applications prosecuted by Jmb Davis Ben-David were allowed, across 1,496 applications in USPTO records.
3.04 office actions per allowed application on average.
74 pending office actions as of October 2026, for 48 clients, before 72 examiners in 50 art units.
